MedicaidPrior AuthMedium impact
Semiannual Medicaid Preferred Drug List Update Scheduled for July 24, 2026
Texas Medicaid·TX·Pharmacy
Effective date
Jul 24, 2026
We identified it
Jun 20, 2026
Summary
Texas Medicaid will update their Preferred Drug List (PDL) on July 24, 2026, adding a new drug class for Duchenne Muscular Dystrophy agents and renaming four existing drug classes. This affects prior authorization requirements for certain medications.
Action Required
By July 24, 2026: Billing and clinical teams must review updated Texas Medicaid PDL for prior authorization requirements on non-preferred drugs in the new Duchenne Muscular Dystrophy Agents class and renamed classes (Calcium Channel Blockers, PAH Agents, Skeletal Muscle Relaxants and Related Agents, Stomach Acid Reducers and Related). Update billing system drug formulary settings and provider alerts for affected medications to ensure proper prior authorization is obtained before prescribing non-preferred drugs.